122 related articles for article (PubMed ID: 32520662)
21. Cytokines and disability in interferon-β-1b treated and untreated women with multiple sclerosis.
Trenova AG; Slavov GS; Manova MG; Kostadinova II
Arch Med Res; 2014 Aug; 45(6):495-500. PubMed ID: 25130430
[TBL] [Abstract][Full Text] [Related]
22. The role of actigraphy in the assessment of primary insomnia: a retrospective study.
Natale V; Léger D; Martoni M; Bayon V; Erbacci A
Sleep Med; 2014 Jan; 15(1):111-5. PubMed ID: 24325809
[TBL] [Abstract][Full Text] [Related]
23. Profiling of Canonical and Non-Traditional Cytokine Levels in Interferon-β-Treated Relapsing-Remitting-Multiple Sclerosis Patients.
D'Angelo C; Reale M; Costantini E; Di Nicola M; Porfilio I; de Andrés C; Fernández-Paredes L; Sánchez-Ramón S; Pasquali L
Front Immunol; 2018; 9():1240. PubMed ID: 29915590
[TBL] [Abstract][Full Text] [Related]
24. Sleep disorders in patients with multiple sclerosis in Spain.
Zhang GX; Zhang WT; Gao SS; Zhao RZ; Yu WJ; Izquierdo G
Neurologia (Engl Ed); 2024; 39(1):29-35. PubMed ID: 38161070
[TBL] [Abstract][Full Text] [Related]
25. Actigraphic features of bipolar disorder: A systematic review and meta-analysis.
De Crescenzo F; Economou A; Sharpley AL; Gormez A; Quested DJ
Sleep Med Rev; 2017 Jun; 33():58-69. PubMed ID: 28185811
[TBL] [Abstract][Full Text] [Related]
26. Long-term use of interferon-β in multiple sclerosis increases Vδ1
Maimaitijiang G; Watanabe M; Shinoda K; Isobe N; Nakamura Y; Masaki K; Matsushita T; Yoshikai Y; Kira JI
J Neuroinflammation; 2019 Sep; 16(1):179. PubMed ID: 31519178
[TBL] [Abstract][Full Text] [Related]
27. Sleep and fatigue in multiple sclerosis: A questionnaire-based, cross-sectional, cohort study.
Nociti V; Losavio FA; Gnoni V; Losurdo A; Testani E; Vollono C; Frisullo G; Brunetti V; Mirabella M; Della Marca G
J Neurol Sci; 2017 Jan; 372():387-392. PubMed ID: 27823835
[TBL] [Abstract][Full Text] [Related]
28. Effects of glatiramer acetate on spasticity in previously interferon-beta-treated and treatment-naive patients with relapsing-remitting multiple sclerosis: a prospective, nonrandomized, open-label, uncontrolled, observational pilot study.
Meca-Lallana JE; de Mingo-Casado P; Amorin-Díaz M; Martínez-Navarro ML; Barreiro AF
Clin Ther; 2010 Jun; 32(6):1061-6. PubMed ID: 20637960
[TBL] [Abstract][Full Text] [Related]
29. Sleep Disorder as a Triggering Factor for Relapse in Multiple Sclerosis.
Sahraian MA; Rezaali S; Hosseiny M; Doosti R; Tajik A; Naser Moghadasi A
Eur Neurol; 2017; 77(5-6):258-261. PubMed ID: 28359058
[TBL] [Abstract][Full Text] [Related]
30. The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Reggio E; Nicoletti A; Fiorilla T; Politi G; Reggio A; Patti F
J Neurol; 2005 Oct; 252(10):1255-61. PubMed ID: 15940386
[TBL] [Abstract][Full Text] [Related]
31. The multidimensional sleep health of individuals with multiple sclerosis and Huntington's disease and healthy controls.
Turner M; Griffiths M; Laws M; Vial S; Bartlett D; Cruickshank T
J Clin Sleep Med; 2024 Jun; 20(6):967-972. PubMed ID: 38305780
[TBL] [Abstract][Full Text] [Related]
32. Sleep actigraphy evidence of improved sleep after treatment of allergic rhinitis.
Yuksel H; Sogut A; Yilmaz H; Yilmaz O; Dinc G
Ann Allergy Asthma Immunol; 2009 Oct; 103(4):290-4. PubMed ID: 19852192
[TBL] [Abstract][Full Text] [Related]
33. Reliability of Actigraphy and Subjective Sleep Measurements in Adults: The Design of Sleep Assessments.
Aili K; Åström-Paulsson S; Stoetzer U; Svartengren M; Hillert L
J Clin Sleep Med; 2017 Jan; 13(1):39-47. PubMed ID: 27707448
[TBL] [Abstract][Full Text] [Related]
34. Fatigue, sleep disturbances and circadian rhythm in multiple sclerosis.
Taphoorn MJ; van Someren E; Snoek FJ; Strijers RL; Swaab DF; Visscher F; de Waal LP; Polman CH
J Neurol; 1993 Jul; 240(7):446-8. PubMed ID: 8410088
[TBL] [Abstract][Full Text] [Related]
35. Actigraphic Analysis of Patients with Cervical Disc Herniation.
Samancioglu A; Akinci E; Osun A; Ganiusmen O; Ozkan U; Temiz C
Turk Neurosurg; 2017; 27(1):104-113. PubMed ID: 27560526
[TBL] [Abstract][Full Text] [Related]
36. Agreement between self-reported sleep patterns and actigraphy in fibromyalgia and healthy women.
Segura-Jiménez V; Camiletti-Moirón D; Munguía-Izquierdo D; Álvarez-Gallardo IC; Ruiz JR; Ortega FB; Delgado-Fernández M
Clin Exp Rheumatol; 2015; 33(1 Suppl 88):S58-67. PubMed ID: 25786045
[TBL] [Abstract][Full Text] [Related]
37. The Use of Actigraphy Differentiates Sleep Disturbances in Active and Inactive Crohn's Disease.
Qazi T; Verma R; Hamilton MJ; Kaplan ER; Redline S; Burakoff R
Inflamm Bowel Dis; 2019 May; 25(6):1044-1053. PubMed ID: 30395256
[TBL] [Abstract][Full Text] [Related]
38. Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder.
Boudebesse C; Geoffroy PA; Bellivier F; Henry C; Folkard S; Leboyer M; Etain B
Chronobiol Int; 2014 Jun; 31(5):698-704. PubMed ID: 24625313
[TBL] [Abstract][Full Text] [Related]
39. Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.
Taheri M; Mirinezhad M; Omrani MD; Sajjadi E; Inoko H; Sayad A
Iran J Allergy Asthma Immunol; 2017 Feb; 16(1):21-27. PubMed ID: 28417621
[TBL] [Abstract][Full Text] [Related]
40. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.
Simone IL; Ceccarelli A; Tortorella C; Bellacosa A; Pellegrini F; Plasmati I; De Caro MF; Lopez M; Girolamo F; Livrea P
Health Qual Life Outcomes; 2006 Dec; 4():96. PubMed ID: 17163989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
